Plant ID: NPO28378
Plant Latin Name: Kokoona ochracea
Taxonomy Genus: Kokoona
Taxonomy Family: Celastraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TAS2R31; | |
TSHR; | |
PTPN11; | |
TERT; | |
SLCO1B3; SLCO1B1; | |
HSF1; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | PTPN11 | Protein-tyrosine phosphatase 2C | Q06124 | CHEMBL3864 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Taste receptor (taste family GPCR) | TAS2R31 | Taste receptor type 2 member 31 | P59538 | CHEMBL2034804 |
Unclassified | HSF1 | Heat shock factor protein 1 | Q00613 | CHEMBL5869 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 7.512E-10 | 1.379E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.255E-08 | 9.107E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.193E-08 | 1.194E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0071280; cellular response to copper ion | 5.221E-08 | 2.274E-04 | CYP1A1, CYP1A2, HSF1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 2.421E-07 | 8.202E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 3.222E-07 | 8.769E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 8.739E-07 | 1.586E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0045931; positive regulation of mitotic cell cycle | 1.400E-06 | 2.177E-03 | CYP1A1, HSF1, PTPN11, TERT |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 2.121E-06 | 2.730E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.131E-06 | 2.730E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0046686; response to cadmium ion | 4.985E-06 | 5.169E-03 | CYP1A2, HSF1, TERT |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 9.886E-06 | 8.969E-03 | CYP1A1, CYP1A2 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 5.383E-05 | 2.859E-02 | SLCO1B1, SLCO1B3 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 3.097E-08 | 1.146E-06 | CYP1A2, CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.610E-06 | 2.979E-05 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 3.184E-06 | 3.926E-05 | CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.002E-05 | 9.272E-05 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.423E-05 | 1.053E-04 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 6.722E-04 | 4.145E-03 | CYP1A2, CYP1A1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 8.014E-04 | 4.236E-03 | SLCO1B1, SLCO1B3 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 3.424E-02 | 8.051E-02 | CYP1A2, CYP1A1, CYP19A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.727E-02 | 7.098E-02 | CYP1A2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.997E-03 | 1.386E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Multiple myeloma | C90 | TERT; |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TERT; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TERT; |
C00-D49: Neoplasms | Prostate cancer | C61 | TERT; |
C00-D49: Neoplasms | Breast cancer | C50 | TERT; CYP19A1; |
H00-H59: Diseases of the eye and adnexa | Ocular inflammation | H16.229 | TERT; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Liver cancer | C22 | TERT; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TERT; |
C00-D49: Neoplasms | Ovarian cancer | C56 | TERT; |
C00-D49: Neoplasms | Melanoma | C43 | TERT; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TERT; |
C00-D49: Neoplasms | Tumors | C00-D48 | TERT; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |